Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1763)
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
116
Price
$234.09
Total Value
$27.15K
Shares Held After
41,786
% of Holdings
0.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
105
Price
$232.57
Total Value
$24.42K
Shares Held After
41,902
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
165
Price
$231.87
Total Value
$38.26K
Shares Held After
42,007
% of Holdings
0.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
1
Price
$229.87
Total Value
$229.87
Shares Held After
42,172
% of Holdings
0.0%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
80
Price
$227.37
Total Value
$18.19K
Shares Held After
42,173
% of Holdings
0.2%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
902
Price
$206.16
Total Value
$185.96K
Shares Held After
149,867
% of Holdings
0.6%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
291
Price
$206.16
Total Value
$59.99K
Shares Held After
187,220
% of Holdings
0.2%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
330
Price
$206.16
Total Value
$68.03K
Shares Held After
222,694
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
150
Price
$206.93
Total Value
$31.04K
Shares Held After
142,295
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
400
Price
$205.31
Total Value
$82.12K
Shares Held After
142,445
% of Holdings
0.3%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
865
Price
$204.47
Total Value
$176.86K
Shares Held After
142,845
% of Holdings
0.6%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
505
Price
$203.32
Total Value
$102.67K
Shares Held After
143,710
% of Holdings
0.4%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
520
Price
$201.60
Total Value
$104.83K
Shares Held After
144,215
% of Holdings
0.4%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
560
Price
$200.95
Total Value
$112.53K
Shares Held After
144,735
% of Holdings
0.4%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
405
Price
$206.16
Total Value
$83.49K
Shares Held After
145,295
% of Holdings
0.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
107
Price
$206.16
Total Value
$22.06K
Shares Held After
255,652
% of Holdings
0.0%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
313
Price
$206.16
Total Value
$64.53K
Shares Held After
57,978
% of Holdings
0.5%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
7,179
Price
$25.03
Total Value
$179.69K
Shares Held After
214,847
% of Holdings
3.2%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
7,144
Price
$22.99
Total Value
$164.22K
Shares Held After
32,600
% of Holdings
18.0%
Avantor, Inc. (AVTR)
Dingemans Simon — Director
Shares
25,000
Price
$8.14
Total Value
$203.50K
Shares Held After
25,000
% of Holdings
100.0%
DAVITA INC. (DVA)
BERKSHIRE HATHAWAY INC — 10% Owner
Shares
1,220,376
Price
$149.84
Total Value
$182.86M
Shares Held After
28,880,209
% of Holdings
4.1%
Privia Health Group, Inc. (PRVA)
Morris Matthew Shawn — Director
Shares
17,096
Price
$24.99
Total Value
$427.23K
Shares Held After
68,188
% of Holdings
20.0%
CERUS CORP (CERS)
Jayaraman Vivek K — Chief Operating Officer
Shares
16,667
Price
$3.00
Total Value
$50.00K
Shares Held After
1,673,374
% of Holdings
1.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
5,467
Price
$18.92
Total Value
$103.45K
Shares Held After
600,004
% of Holdings
0.9%
Butterfly Network, Inc. (BFLY)
Carlson Megan — CAO and SVP, Finance
Shares
110,422
Price
$4.75
Total Value
$524.39K
Shares Held After
507,209
% of Holdings
17.9%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,795
Price
$6.01
Total Value
$34.83K
Shares Held After
271,774
% of Holdings
2.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,625
Price
$63.48
Total Value
$103.16K
Shares Held After
38,498
% of Holdings
4.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
1,104
Price
$425.02
Total Value
$469.22K
Shares Held After
20,729
% of Holdings
5.1%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
21,097
Price
$54.04
Total Value
$1.14M
Shares Held After
65,623
% of Holdings
24.3%
Kiniksa Pharmaceuticals International, plc (KNSA)
Paolini John F. — CHIEF MEDICAL OFFICER
Shares
37,327
Price
$53.52
Total Value
$2.00M
Shares Held After
86,720
% of Holdings
30.1%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
1,431
Price
$74.45
Total Value
$106.53K
Shares Held After
11,014
% of Holdings
11.5%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
8,680
Price
$73.35
Total Value
$636.70K
Shares Held After
12,445
% of Holdings
41.1%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
124
Price
$99.97
Total Value
$12.40K
Shares Held After
85,533
% of Holdings
0.1%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
7,434
Price
$99.29
Total Value
$738.12K
Shares Held After
85,657
% of Holdings
8.0%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
3,872
Price
$98.42
Total Value
$381.08K
Shares Held After
93,091
% of Holdings
4.0%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
2,243
Price
$32.79
Total Value
$73.55K
Shares Held After
36,621
% of Holdings
5.8%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$203.33
Total Value
$1.22M
Shares Held After
378,682
% of Holdings
1.6%
CORCEPT THERAPEUTICS INC (CORT)
BELANOFF JOSEPH K — Director
Shares
40,000
Price
$50.10
Total Value
$2.00M
Shares Held After
2,878,326
% of Holdings
1.4%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
143
Price
$31.00
Total Value
$4.43K
Shares Held After
66,083
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
14,023
Price
$30.16
Total Value
$422.99K
Shares Held After
66,226
% of Holdings
17.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
800
Price
$234.02
Total Value
$187.21K
Shares Held After
41,382
% of Holdings
1.9%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,420
Price
$232.92
Total Value
$330.75K
Shares Held After
42,182
% of Holdings
3.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
780
Price
$232.04
Total Value
$180.99K
Shares Held After
43,602
% of Holdings
1.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
370
Price
$230.87
Total Value
$85.42K
Shares Held After
44,382
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
98
Price
$229.71
Total Value
$22.51K
Shares Held After
44,752
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
932
Price
$228.75
Total Value
$213.20K
Shares Held After
44,850
% of Holdings
2.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
600
Price
$227.45
Total Value
$136.47K
Shares Held After
45,782
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
289
Price
$83.16
Total Value
$24.03K
Shares Held After
173,371
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
900
Price
$82.60
Total Value
$74.34K
Shares Held After
173,660
% of Holdings
0.5%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
811
Price
$81.02
Total Value
$65.71K
Shares Held After
174,560
% of Holdings
0.5%
Showing 851–900 of 1763 transactions (page 18 of 36)